EUVIMEDEUVIMED entdecken
Crossref

LATEST ADVANCES FOR TREATING CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY

Ecesu Çetin, Mehmet Burak

Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi · 11.03.2025 · 88 (2) · 155-163

DOI: 10.26650/iuitfd.1626109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi, online erschienen am 11.03.2025. Verfasst von Ecesu Çetin und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Çetin, E., & Burak, M. (2025). LATEST ADVANCES FOR TREATING CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY. Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi, 88(2), 155-163. https://doi.org/10.26650/iuitfd.1626109

Vancouver

Çetin E, Burak M. LATEST ADVANCES FOR TREATING CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY. Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi. 2025;88(2):155-163. doi:10.26650/iuitfd.1626109

BibTeX
@article{etin2025,
  author = {Çetin, Ecesu and Burak, Mehmet},
  title = {LATEST ADVANCES FOR TREATING CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY},
  journal = {Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi},
  year = {2025},
  volume = {88},
  number = {2},
  pages = {155--163},
  doi = {10.26650/iuitfd.1626109}
}
Kostenlos starten →